Please login to the form below

Not currently logged in
Email:
Password:

Gyros Protein Technologies appoints chairman

Dr Frank Witney brings experience from Affymetrix and Dionex

Gyros Protein Technologies Dr Frank WitneySwedish Gyros Protein Technologies has appointed Dr Frank Witney as the new chairman of its board, succeeding David Patteson.

Dr Witney brings over 30 years of leadership experience in the life sciences industry, most recently having served as president and chief executive officer of Affymetrix.

He has held a number of executive roles in recent years, including serving as president and chief executive of both Dionex and Panomics, and was Packard Biosciences' chief operating officer before becoming president of life sciences after the firm's acquisition by Perkin Elmer.

Dan Calvo, Gyros Protein Technologies' chief executive, said: “We are delighted that Frank has joined as chairman.

“He brings with him a wealth of experience and knowledge in the field, and his guidance will be invaluable as we work to build Gyros Protein Tehcnologies following the merger earlier this year.”

23rd June 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Digital
Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...

Infographics